Lytix Biopharma ASA LYTIX

OSL · Norway · Health Technology

NOK 8.26-0.50 (-5.71%)

Market closed· Oct 1, 2026, 2:25 PM UTC· NOK · Data may be delayed

Company news

Yahoo FinanceJul 07, 2026

Levicept Appoints Darlene Deptula-Hicks as CFO

Highly Experienced US-Based Public Markets Leader Strengthens Team as Company Drives Late Stage Development of LEVI-04 for OsteoarthritisSANDWICH, United Kingdom, July 07, 2026 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), today announces the appointment of Darlene Deptula-Hicks as Chief Financial Officer (CFO). Darlene has a wealth of international experience in the biotechnology and pharmaceu

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.